Screener
Stoke Therapeutics, Inc. STOK Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash - long-term | 3,227 | 227 |
| Operating lease right-of-use assets | 2,493 | 3,101 |
| Property and equipment, net | 3,395 | 3,146 |
| Total assets | $443,277 | $418,434 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $6,839 | $4,939 |
| Accrued and other current liabilities | 23,901 | 41,035 |
Item 1. Financial Statements.
FAQ
- What is Stoke Therapeutics, Inc.'s total assets?
- Stoke Therapeutics, Inc. (STOK) reported total assets of $443.28M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s total assets changed year-over-year?
- Stoke Therapeutics, Inc.'s total assets increased by 8.9% year-over-year, from $406.89M to $443.28M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s total assets has grown at a 7.0% compound annual growth rate (CAGR), from $297.93M to $418.43M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Stoke Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude